Digital Therapeutics Market Is Projected to Gain $22.60 Billion By 2031, Growing at a 19.4% CAGR: Allied Market Research
23 oct. 2023 22h00 HE
|
Allied Market Research
Wilmington, Delaware, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global digital therapeutics market size was estimated at $3.84 billion and is projected to gain $22.60 billion in 2031, exhibiting a...
Studies Investigate the Impact of Obesity on Outcomes after the Total Ankle Replacement (TAR) Procedure
17 oct. 2023 16h00 HE
|
American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Total Ankle Replacement (TAR), also known as total ankle arthroplasty, is a surgical procedure that foot and ankle orthopaedic surgeons use to treat...
A Game Changer: Exerkine Corporation Leap Frogs into its Commercial Phase
17 oct. 2023 05h32 HE
|
Exerkine Corporation
A Game Changer: Exerkine Corporation Leap Frogs into its Commercial Phase.
Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
17 oct. 2023 02h00 HE
|
Zealand Pharma
Press release – No. 13 / 2023 Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek Copenhagen, Denmark, October 17, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no....
How Well Are Canadians Supported for Obesity While Being Treated for Related Chronic Diseases?
02 oct. 2023 07h00 HE
|
Obesity Canada
EDMONTON, Alberta, Oct. 02, 2023 (GLOBE NEWSWIRE) -- More than two years after the publication of landmark Canadian clinical practice guidelines for treating obesity in adults, many patients...
Vice Health and Wellness Using AI to Change the Way We Lose Weight and Manage Addiction
26 sept. 2023 08h45 HE
|
Vice Health and Wellness Inc.
NEW YORK, NY, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Vice Health and Wellness Inc. (Vice) (CSE: VICE) (OTC Pink: VICFF) is embracing artificial intelligence (AI) and cutting-edge nutraceutical...
SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023
08 sept. 2023 05h00 HE
|
Zealand Pharma
Press release – No. 11 / 2023 SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023 Copenhagen, Denmark, September 8, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL)...
Escalating Obesity Epidemic Drives Growth of Global Obesity Treatment Market, Estimated to be $16.54 Billion in 2023, with a Strong CAGR of 9.84%
29 août 2023 09h43 HE
|
Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Global Obesity Treatment Market (2023-2028) by Treatment and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been...
Global Obesity Market Analysis Report 2023-2029: Shifting Diet Habits, Globalization, and Food Accessibility Driving Growth
24 août 2023 06h43 HE
|
Research and Markets
Dublin, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The "Global Obesity Market (2023 Edition) - Analysis By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Others), Age Group, By...
Zealand Pharma Announces Financial Results for the First Half of 2023
17 août 2023 01h00 HE
|
Zealand Pharma
Company announcement - No. 28 / 2023 Zealand Pharma Announces Financial Results for the First Half of 2023 Strong progress across R&D pipeline and significant strengthening of the balance...